Ex vivo myeloid differentiation of cord blood CD34+ cells: Comparison of four serum-free media containing bovine or human albumin

Cytotherapy

Volumn 5, Issue 2, 2003, Pages 153-160

  De Bruyn, Cecile ^a   Delforge, A ^a   Bron, D ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Cord blood; Ex vivo expansion; Myeloid differentiation; Serum free media

Indexed keywords

ALBUMIN; BOVINE SERUM ALBUMIN; CD11B ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 3; LACTOFERRIN; MYELOPEROXIDASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL STIMULATION; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MONONUCLEAR CELL; PHAGOCYTE; PHAGOCYTOSIS; PROMYELOCYTE; SCREENING; TYPES OF STUDY; UMBILICAL CORD BLOOD;

EID: 0038585035     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/1465324031001055     Document Type: Article

References (35)

1. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
2. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000;28:1197-205.
3. McNiece I, Jones R, Cagnoni P et al. Ex-vivo expansion of hematopoietic progenitor cells: Preliminary results in breast cancer. Hematol Cell Ther 1999;41:82-6.
4. Zimmerman TM, Lee WJ, Bender JG et al. Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue. Bone Marrow Transplant 2000;26:505-10.
5. Paquette RL, Dergham ST, Karpf E et al. Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery. Exp Hematol 2002;30:374-80.
6. Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-76.
7. McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002;30:612-6.
8. Sandstrom CE, Collins PC, McAdams TA et al. Comparison of whole serum-deprived media for ex vivo expansion of hematopoietic progenitor cells from cord blood and mobilized peripheral blood mononuclear cells. J Hematother 1996;5:461-73.
9. Lam AC, Li K, Zhang XB, Li CK et al. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: Duration of culture; The media, serum supplements, and growth factors used; And engraftment in NOD/SCID mice. Transfusion 2001;41:1567-76.
10. Van De Oudenrijn S, Von Dem Borne AE, De Haas M. Influence of medium components on ex vivo megakaryocyte expansion. J Hematother Stem Cell Res 2001;10:193-200.
11. De Bruyn C, Delforge A, Bernier M, Bron D. Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells. Cytotherapy 2003;5:87-98.
12. Babior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978;298:659-68.
13. Pryzwansky KB, Martin LE, Spitznagel JK. Immunocytochemical localization of myeloperoxidase, lactoferrin, lysozyme and neutral proteases in human monocytes and neutrophilic granulocytes. J Reticuloendothel Soc 1978;24:295-310.
14. Oseas R, Yang HH, Baehner RL, Boxer LA. Lactoferrin: A promoter of polymorphonuclear leukocyte adhesiveness. Blood 1981;57:939-45.
15. Neildez-Nguyen TM, Vetillard J, Drouet M et al. Functional studies of maturing myeloid cells during ex vivo expansion for treatment of aplasia: Feasibility of ex vivo expansion from cryopreserved bone marrow cell samples. J Hematother 1998;7:69-79.
16. Terstappen LW, Saffrod M, Loken MR. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia 1990;4:657-63.
17. Terstappen LW, Buescher S, Nguyen M, Reading C. Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry. Leukemia 1992;6:1001-10.
18. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 1971;134:907-34.
19. Nagel JE, Han K, Coon PJ et al. Age differences in phagocytosis by polymorphonuclear leukocytes measured by flow cytometry. J Leukoc Biol 1986;39:399-407.
20. + cells and myeloid progenitors. Cytokines Cell Mol Ther 1998;4:257-64.
21. Mackin W, Gunter KC, Kraus M. The frontier of cellular medicine: Expanding umbilical cord blood stem cells for clinical use. Cancer J 2001;7:S95-S105.
22. Mellado-Damas N, Rodriguez JM, Carmona M et al. Ex-vivo expansion and maturation of CD34-positive hematopoietic progenitors optimization of culture conditions. Leuk Res 1999;23:1035-40.
23. Kohler T, Plettig R, Wetzstein W et al. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells 1999;17:19-24.
24. + cells during ex vivo expansion using thrombopoietin, flt3-ligand and/or granulocyte-colony stimulating factor. Br J Haematol 1999;105;1034-40.
25. Sawai N, Koike K, Ito S et al. Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34(+) cord blood cells in long-term serum-deprived liquid culture. Blood 1999;93:509-18.
26. + umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. J Hematother Stem Cell Res 1999;8:609-18.
27. Won JH, Cho SD, Park SK et al. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells. J Hematother Stem Cell Res 2000;9:465-73.
28. Flores-Guzman P, Gutierrez-Rodriguez M, Mayani H. In vitro proliferation, expansion, and differentiation of a CD34(+) cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. Arch Med Res 2002;33:107-14.
29. Stiff P, Chen B, Franklin W et al. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 2000;95:2169-74.
30. Ueda T, Tsuji K, Yoshino H et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 2000;105:1013-21.
31. Gilmore GL, DePasquale DK, Lister J, Shadduck RK. Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells. Exp Hematol 2000;28:1297-305.
32. Roßmanith T, Schröder B, Bug G et al. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of SCID repopulating cells. Stem Cells 2001;19:313-20.
33. + cells. Br J Haematol 2002;117:924-34.
34. Merten OW. Safety issues of animal products used in serum-free media. Dev Biol Stand 1999;99:167-180.
35. + peripheral blood cells. J Leukoc Biol 1997;62:480-484.